Until recently, tamoxifen, a nonsteroidal antiestrogen, was the mainstay of endocrine treatment of breast cancer. However, new aromatase inhibitors that are many times more potent and specific than…
Category: October Surprise 2024
Category Added in a WPeMatico Campaign
